Samsung hopes to expand U.S. reach with replica drugs
May 23, 2016 at 18:22 PM EDT
Samsung Group said Tuesday its near-replica of Johnson & Johnson’s blockbuster arthritis drug Remicade has been accepted for review by the U.S. Food and Drug Administration, marking the South Korean conglomerate’s first attempt to sell drugs to Americans, alongside its popular smartphones and televisions.